Table 2. Criteria Considered in the 3 Decision-Making Approaches for Vaccine Product Prioritization .

Criterion	Considered by ACIP	Considered by NLEM	Identified by Stakeholders Through TSE Approach
Disease burden	Yes	Yes	Yes (under ‘health impact’)
Disease prevalence	Yes	Yes	Yes (under ‘health impact’)
Vaccine efficacy	Yes	Yes	Yes (under ‘health impact’)
Vaccine safety	Yes	Yes	Yes
Budget impact	Yes	Yes	Yes
Cost-effectiveness	No	Yes	Yes
Capacity for local manufacturing	Yes	No	No
Equity	No	Yes	No
Delivery cost	No	No	Yes

Abbreviations: ACIP, Advisory Committee on Immunization Practices; NLEM, National List of Essential Medicine; TSE, Total System Effectiveness.